Medicare Enrolled
Dr. Perminder Bhatia, MD
Neurology · Fresno, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bhatia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhatia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bhatia
Dr. Perminder Bhatia is a neurology specialist in Fresno, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bhatia performed 5,425 Medicare services across 3,624 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bhatia received a total of $204,950 from 114 pharmaceutical and/or device companies across 1809 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bhatia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 14% volume in CA
$204,950 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,425
Medicare services
Top 14% in CA for neurology
3,624
Unique beneficiaries
$112
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~286 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,877 | $98 | $194 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
693 | $68 | $137 |
| Principal care management for high-risk disease, first 30 minutes This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month. |
629 | $62 | $122 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
355 | $80 | $152 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
315 | $374 | $705 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
284 | $230 | $431 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
278 | $129 | $251 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
225 | $47 | $92 |
| New patient office visit, complex (60-74 min) | 158 | $175 | $331 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
119 | $110 | $207 |
| Brain stimulator programming, first 15 minutes Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes. |
92 | $40 | $75 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
69 | $42 | $205 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
61 | $145 | $271 |
| Brain stimulator programming, additional 15 minutes Electronic analysis and programming of an implanted brain neurostimulator generator by a qualified health professional. This code applies to each additional 15-minute increment beyond the initial service. |
53 | $34 | $65 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
35 | $117 | $248 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
34 | $29 | $58 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $145 | $271 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
28 | $41 | $110 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
27 | $163 | $544 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
25 | $105 | $196 |
| Video EEG monitoring, 2-12 hours This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report. |
22 | $104 | $352 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
16 | $32 | $86 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$204,950
Total received (2018-2024)
Avg $29,279/year across 7 years
Top 4% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
114
Companies
1,809
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$143,905 (70.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$37,814 (18.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,231 (11.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$76,195
2023
$29,559
2022
$22,569
2021
$21,333
2020
$28,199
2019
$17,503
2018
$9,592
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$16,659
Lilly USA, LLC
$15,843
Eisai Inc.
$15,626
Otsuka America Pharmaceutical, Inc.
$14,554
ABBVIE INC.
$7,142
Ipsen Innovation
$2,155
MDD US Operations, LLC
$613
Alexion Pharmaceuticals, Inc.
$261
UCB, Inc.
$253
ANI Pharmaceuticals, Inc.
$250
SK Life Science, Inc.
$246
Neurocrine Biosciences, Inc.
$225
Octapharma USA, Inc.
$173
Genentech USA, Inc.
$171
ARGENX US, INC.
$159
Neurelis, Inc.
$153
EMD Serono, Inc.
$151
HARMONY BIOSCIENCES LLC
$146
Novartis Pharmaceuticals Corporation
$140
Biogen, Inc.
$111
Lundbeck LLC
$95
Amneal Pharmaceuticals LLC
$91
CATALYST PHARMACEUTICALS, INC.
$87
Takeda Pharmaceuticals U.S.A., Inc.
$84
NEUROPACE, INC.
$81
Amgen Inc.
$66
PFIZER INC.
$65
CSL Behring
$59
Vanda Pharmaceuticals Inc.
$57
AstraZeneca Pharmaceuticals LP
$46
SCILEX PHARMACEUTICALS INC.
$45
Ipsen Biopharmaceuticals, Inc
$42
Merz Pharmaceuticals, LLC
$41
TG Therapeutics, Inc.
$38
Celgene Corporation
$36
Azurity Pharmaceuticals, Inc.
$36
Sumitomo Pharma America, Inc.
$35
LivaNova USA, Inc.
$24
GE HEALTHCARE
$21
Harmony Biosciences Llc
$20
JAZZ PHARMACEUTICALS INC.
$18
Abbott Laboratories
$17
Averitas Pharma Inc.
$16
Kyowa Kirin, Inc.
$16
BANNER LIFE SCIENCES, LLC
$14
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
Top 3 companies account for 63.2% of 2024 payments
All-time payments by company (2018-2024) ›
SK Life Science, Inc.
$28,223
Otsuka America Pharmaceutical, Inc.
$25,235
Teva Pharmaceuticals USA, Inc.
$18,252
Eisai Inc.
$16,124
Lilly USA, LLC
$16,089
Allergan, Inc.
$15,012
Acorda Therapeutics, Inc
$12,608
AbbVie Inc.
$12,396
ABBVIE INC.
$7,573
ARGENX US, INC.
$5,474
Biohaven Pharmaceuticals, Inc.
$3,354
Boston Scientific Corporation
$3,347
LivaNova USA, Inc.
$2,812
UCB, Inc.
$2,782
Mallinckrodt LLC
$2,730
Biohaven Pharmaceutical Holding Company Ltd.
$2,454
Novartis Pharmaceuticals Corporation
$2,210
Ipsen Innovation
$2,155
MDD US Operations, LLC
$1,769
Alexion Pharmaceuticals, Inc.
$1,656
Biogen, Inc.
$1,641
Janssen Pharmaceuticals, Inc
$1,491
BOSTON SCIENTIFIC CORPORATION
$1,327
Vertical Pharmaceuticals, LLC
$1,146
BANNER LIFE SCIENCES, LLC
$1,104
Neurocrine Biosciences, Inc.
$1,008
Allergan Inc.
$977
Banner Life Sciences, LLC
$944
EMD Serono, Inc.
$923
Genentech USA, Inc.
$752
ACADIA Pharmaceuticals Inc
$681
Kyowa Kirin, Inc.
$624
Sunovion Pharmaceuticals Inc.
$553
Lundbeck LLC
$545
Amneal Pharmaceuticals LLC
$507
Supernus Pharmaceuticals, Inc.
$483
GENZYME CORPORATION
$408
Amgen Inc.
$363
Takeda Pharmaceuticals U.S.A., Inc.
$359
ANI Pharmaceuticals, Inc.
$357
Mallinckrodt Hospital Products Inc.
$333
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$284
CSL Behring
$283
Ipsen Biopharmaceuticals, Inc
$279
Avanir Pharmaceuticals, Inc.
$257
AstraZeneca Pharmaceuticals LP
$255
Neurelis, Inc.
$252
Celgene Corporation
$224
Harmony Biosciences LLC
$218
Octapharma USA, Inc.
$215
PFIZER INC.
$208
Adamas Pharmaceuticals, Inc.
$188
EISAI INC.
$182
BioDelivery Sciences International, Inc.
$173
Horizon Therapeutics plc
$164
Abbott Laboratories
$161
GE HEALTHCARE
$149
CATALYST PHARMACEUTICALS, INC.
$149
HARMONY BIOSCIENCES LLC
$146
Sumitomo Pharma America, Inc.
$133
Merz Pharmaceuticals, LLC
$102
Pernix Therapeutics Holdings, Inc.
$102
NEUROPACE, INC.
$100
GE HealthCare
$99
Medtronic, Inc.
$98
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
E.R. Squibb & Sons, L.L.C.
$87
Merck Sharp & Dohme Corporation
$77
Alnylam Pharmaceuticals Inc.
$70
Exeltis, USA Inc.
$67
AbbVie, Inc.
$67
IDORSIA PHARMACEUTICALS US INC
$63
IMPEL PHARMACEUTICALS INC.
$58
Catalyst Pharmaceuticals, Inc.
$57
Vanda Pharmaceuticals Inc.
$57
Scilex Pharmaceuticals Inc.
$55
Daiichi Sankyo Inc.
$51
Upsher-Smith Laboratories LLC
$47
SCILEX PHARMACEUTICALS INC.
$45
Otsuka Pharmaceutical Development & Commercialization, Inc.
$43
Arbor Pharmaceuticals, Inc.
$43
TG Therapeutics, Inc.
$38
Nevro Corp.
$37
Zogenix Inc.
$37
US WorldMeds, LLC
$37
Impax Laboratories, Inc.
$36
UPSHER-SMITH LABORATORIES LLC
$36
Azurity Pharmaceuticals, Inc.
$36
ARBOR PHARMACEUTICALS, INC.
$34
Merz North America, Inc.
$33
Egalet US Inc
$32
Axsome Therapeutics, Inc.
$29
Greenwich Biosciences, Inc.
$26
Mallinckrodt Enterprises LLC
$25
INSIGHTEC,INC
$24
Harmony Biosciences Llc
$20
Mitsubishi Tanabe Pharma America, Inc.
$20
Akcea Therapeutics, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$18
JAZZ PHARMACEUTICALS INC.
$18
Shionogi Inc
$18
Zyla Life Sciences, Inc.
$17
Grifols USA, LLC
$17
Virtus Pharmaceuticals LLC
$17
IBSA Pharma Inc.
$17
GRT US Holding, Inc.
$17
Averitas Pharma Inc.
$16
AQUESTIVE THERAPEUTICS, INC.
$15
Horizon Pharma plc
$14
Life Molecular Imaging Ltd
$14
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
RedHill Biopharma Inc.
$13
Sentynl Therapeutics, Inc.
$13
Piramal Imaging Limited
$12
Top 3 companies account for 35.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPLATZER TALISMAN · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adempas · Aimovig · Austedo XR · Auvelity · BAFIERTAM · BELBUCA · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · BUNAVAIL 2.1 mg 30-count box · Bafiertam · Briviact · COMIRNATY · COPAXONE · Cenobamate · DUEXIS · DUOPA · DYSPORT · Duopa · Dysport · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Exablate · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GENERAL DBS · GENERAL DBS · GENERAL DBS · GENERAL PAIN MANAGEMENT · GILENYA · GIVLAARI · GOCOVRI · Gamunex-C · General - DBS · Gocovri · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LEVORPHANOL TARTRATE · LYRICA · Leqembi · Levorphanol · Licart · MAVENCLAD · MAYZENT · MOVANTIK · MYOBLOC · Mavenclad · Morphabond ER · Movantik · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · ONFI · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PANZYGA · PENNSAID · PONVORY · PROCLAIM · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RADICAVA · RELISTOR · REXULTI · REYVOW · RNS Neurostimulator Kit · RNS System · RYTARY · Rystiggo · SOLIRIS · SPRIX · SYMPAZAN · SYNCHROMEDII · Senza · Sohonos · Soliris · Strensiq · Symproic · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · Wakix · XCOPRI · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for neurology in CA.
Geographic Context
Neurologists within 10 mi
33
Per 100K population
3.3
County median income
$71,434
Nearest hospital
FRESNO SURGICAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bhatia is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with speaking/promotional industry engagement in the top 4% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bhatia experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bhatia performed 1,877 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bhatia receive payments from pharmaceutical companies?
Yes. Dr. Bhatia received a total of $204,950 from 114 companies across 1,809 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhatia's costs compare to other neurologists in Fresno?
Dr. Bhatia's average Medicare payment per service is $112. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhatia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Fresno
Browse neurologists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology